Gordian Surgical, a Tel Aviv, Israel-based developer of a trocar with a built-in device for safe fascia closure, recently completed a $1m raise.
Participants in the raise included angel investors, surgeons, and a private investment fund.
The company intends to use the funds to finalize product design, receive regulatory clearance (FDA and CE mark), and perform clinical validations.
Led by Zvi Pe’er, CEO, Gordian Surgical develops a two-in-one trocar with a built-in closure device, which aims to offers a safe approach for opening and suturing abdominal incisions during laparoscopic procedures. Instead of inserting the sutures at the end of the procedure, they are inserted into the tissue surrounding the opening at the beginning of the procedure. The sutures and anchors to hold them stay in place throughout the operation the incisions are closed when the trocar is removed.
Goridal is a portfolio company of Trendlines Medical.
FinSMEs
29/04/2014